<DOC>
	<DOCNO>NCT00306228</DOCNO>
	<brief_summary>The conceptual hypothesis study , patient acute myocardial infarction ST-segment elevation , strategy perform coronary angioplasty culprit artery paclitaxel elute stent significantly reduce rate restenosis comparison bare stent . The conceptual hypothesis study , patient acute myocardial infarction ST-segment elevation , strategy perform coronary stent-angioplasty culprit artery protection tirofiban 120 minute fibrinolytic significantly improve epicardial myocardial infusion comparison strategy perform immediate intravenous thrombolysis ( tenecteplase plus enoxaparine ) follow coronary angiography adequate revascularization .</brief_summary>
	<brief_title>Role Tirofiban Paclitaxel Eluting Stent Postfibrinolysis Angioplasty</brief_title>
	<detailed_description>The primary objective study : first determine efficacy paclitaxel elute stent compare conventional bare stent term restenosis , second determine effect tirofiban administer prior percutaneous coronary intervention ( PCI ) 120 minute thrombolytic epicardial myocardial flow mechanical revascularization patient STEMI . Methods : This phase 4 , 2x2 randomise , open , multicenter , clinical study . Patients randomise 1:1:1:1 four group : ) paclitaxel elute stent tirofiban , b ) paclitaxel elute stent without tirofiban , c ) bare stent tirofiban ) bare stent without tirofiban . A total approximately 436 patient , &lt; 12 hour STEMI enrol . All patient initially treat tenecteplase ( TNK ) enoxaparin . Tirofiban start 120 minute tenecteplase administration patient randomise tirofiban . Cardiac catheterization perform within first 3-12 hour study inclusion stenting culprit artery , randomise paclitaxel bare stent , perform . The efficacy strategy measure term : 1 ) binary restenosis , define &gt; 50 % diameter stenosis segment analysis include stented segment well margin , 5 mm proximal distal stent 9-12 month follow-up , 2 ) assessment epicardial myocardial perfusion ( % TIMI 3 , CTFC , CFR-CTFC , TMP DSA-TMP analysis normalization ST segment 90 minute , 3 , 6 , 12 24 hour thrombolysis ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>Patients STsegment elevation acute myocardial infarction follow criterion eligible enrollment : 1 . Age &gt; 18 year . 2 . Chest discomfort &gt; 30 minute response nitroglycerin . 3 . Time onset symptoms randomization &lt; 12 hour . 4 . ST segment elevation &gt; 1 mm two limb lead 2 mm two contiguous precordial lead nondiagnostic ECG ( leave bundle branch block pacemaker rhythm ) classic symptom . 5 . Killip class &gt; 3 . 6 . Written inform consent obtain . Patients present follow include study . 1 . Cardiogenic shock define systolic blood pressure &lt; 90 mm Hg without response fluid administration &lt; 100 mmHg patient supportive treatment bradycardia . 2 . Suspected mechanical complication acute myocardial infarction . 3 . Previous CABG . 4 . Noncardiac disease likely jeopardize plan termination study . 5 . Woman childbearing potential unless negative pregnant test . 6 . Active bleeding recent ( within 2 week ) surgery contraindicate use heparin , tirofiban , platelet aggregation inhibitor . 7 . Contraindications thrombolytic use . previous hemorrhagic stroke time history prior nonhemorrhagic cerebrovascular accident within 12 month intracerebral neoplasia active internal bleeding suspect aortic dissection Uncontrolled hypertension &gt; 180/110 several measurement know intracerebral pathology cover contraindication Current use anticoagulant heparin use within 8 hour know bleed diathesis recent trauma ( &lt; 4 week ) , include head trauma traumatic prolonged ( &gt; 10 minute ) CPR recent major surgery biopsy ( &lt; 8 week ) noncompressible vascular puncture recent ( &lt; 4 week ) internal bleeding pregnancy active peptic ulcer 8 . History hypersensitivity aspirin , ticlopidine , clopidogrel , heparin , tirofiban stainless steel . 9 . Known renal failure , creatinine &gt; 2,5 mg/dL . 10 . Known impaired hepatic function contraindicates use clopidogrel . 11 . Known thrombocytopenia ( 100.000 ) . 12 . Participation trial . 13 . Known multivessel disease identify suitable revascularization . 14 . Known peripheral vascular disease difficult cardiac catheterization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>ST elevation acute myocardial infarction</keyword>
	<keyword>Thrombolysis</keyword>
	<keyword>Early routine percutaneous coronary intervention</keyword>
	<keyword>tirofiban</keyword>
	<keyword>paclitaxel</keyword>
</DOC>